Furthermore, to implement the cytoprotection concept in eye therapy, in particular in corneal neovascularization counteraction by treatment of corneal neovascularization (corticosteroid, NSAIDs, cyclosporine A, anti-VEGF drops), perceiving BPC 157 corneal ulcer healing capability as a whole was carried out, respecting the mentioned agents used in the treatment of corneal neovascularization as a class. The gene discussed is VEGFA; the disease is corneal infection.